| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | Chief Strategy Officer | Earnout Rights (Restricted Stock Units) | 145,681 | 22 Oct 2021 | Direct | ||
| SAB Biotherapeutics, Inc. | Chief Strategy Officer | Employee Stock Option (right to buy) | 11,632 | 22 Oct 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics, Inc. | 22 Oct 2021 | 5 | $0 | 4 | Chief Strategy Officer | 26 Oct 2021, 21:46 |
| SABS | Big Cypress Acquisition Corp. | 22 Oct 2021 | 0 | $0 | 3 | Chief Strategy Officer | 22 Oct 2021, 21:25 |